Stay updated on Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not be about the study. The revision note shows the page updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe notice about government funding and operating status at the top of the page was removed, an administrative banner that does not alter the study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedNo significant changes detected; the page's study details, eligibility criteria, and plan remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.